Summary

Consumer concerns over excess weight are rising, partly due to consumers becoming more focused on maintaining good health in the wake of the COVID-19 pandemic, with this benefiting sales of health and wellness staple foods in New Zealand. There is growing awareness of the impact that excess weight can have on heart health and the immune system, with more importance placed on healthier diets as a result. A growing focus on weight and diet is also linked to an ongoing rise in the share of the popu...

Euromonitor International's HW Staple Foods in New Zealand report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2019-2023, allowing you to compare health and wellness categories with each other or in the context of the total market for a sector. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, legislative context or lifestyle influences. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: HW Baked Goods, HW Breakfast Cereals, HW Processed Fruit and Vegetables, HW Processed Meat, Seafood and Alternatives to Meat, HW Rice, Pasta and Noodles, HW Staple Foods by Type.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the HW Staple Foods market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

ページTOPに戻る

Table of Contents

HW Staple Foods in New Zealand
Euromonitor International
October 2024

List Of Contents And Tables

HW STAPLE FOODS IN NEW ZEALAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Growing interest in keto diets encourages innovation
Gluten free remains the largest claim in health and wellness staple foods
Vegan and vegetarian staple foods struggle due to cost and health concerns as many opt for natural alternatives
PROSPECTS AND OPPORTUNITIES
Opportunities for growth in sales of private label health and wellness staple foods
Vegan and vegetarian claims return to good growth as inflation softens and health, environmental and ethical concerns intensify
Packaged flat bread likely to offer a nexus of innovative claim combinations in forecast period
CATEGORY DATA
Table 1 Sales of Staple Foods by Health and Wellness Type: Value 2019-2023
Table 2 Sales of Staple Foods by Health and Wellness Type: % Value Growth 2019-2023
Table 3 Company Shares of Gluten Free Staple Foods (Biggest HW Type in Global Staple Foods): % Value 2019-2023
Table 4 Company Shares of Organic Staple Foods (2nd Biggest HW Type in Global Staple Foods): % Value 2019-2023
Table 5 Company Shares of High Fibre Staple Foods (3rd Biggest HW Type in Global Staple Foods): % Value 2019-2023
Table 6 Company Shares of Vegetarian Staple Foods (4th Biggest HW Type in Global Staple Foods): % Value 2019-2023
Table 7 Company Shares of No Allergens Staple Foods (5th Biggest HW Type in Global Staple Foods): % Value 2019-2023
Table 8 Forecast Sales of Staple Foods by Health and Wellness Type: Value 2023-2028
Table 9 Forecast Sales of Staple Foods by Health and Wellness Type: % Value Growth 2023-2028
HEALTH AND WELLNESS IN NEW ZEALAND
EXECUTIVE SUMMARY
Health and wellness in focus
Consumer weight trends
Consumer diet trends
Health-related deaths
Blood pressure and cholesterol levels
Diabetes prevalence
DISCLAIMER